|
May I add to what Greg said - the first NIH trials with Promacta were with their Aplastic Anemia patients. They had such good luck with platelets and red cells that they decided to give it a try with their MDS patients. But whatever the disease, they are on the cutting edge - and as Greg said - all expenses at NIH are free to the patient.
God Bless,
Sally
|